PMID- 32572628
OWN - NLM
STAT- MEDLINE
DCOM- 20210720
LR  - 20210720
IS  - 1432-2218 (Electronic)
IS  - 0930-2794 (Linking)
VI  - 35
IP  - 4
DP  - 2021 Apr
TI  - Efficacy comparison of laparoscopic sleeve gastrectomy in type 2 diabetes 
      patients with a BMI 30-34.9 kg/m(2) versus BMI < 30 kg/m(2).
PG  - 1544-1550
LID - 10.1007/s00464-020-07749-4 [doi]
AB  - BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) is safe and effective in type 2 
      diabetes mellitus (T2DM) with body mass index (BMI) >/= 35 kg/m(2). However, the 
      effect and safety of LSG in the treatment of T2DM patients with BMI less than 
      35 kg/m(2), especially in patients with BMI less than 30 kg/m(2), are still 
      debatable. METHODS: A total of 51 T2DM patients with BMI less than 35 kg/m(2) 
      treated successfully with LSG were included in our study. All patients were 
      divided into two groups for subgroup analysis, namely group A (BMI 
      23.23-29.97 kg/m(2)) and group B (BMI 30.0-34.9 kg/m(2)). The weight loss and 
      diabetic characteristics of LSG in the two groups at 3 months, 6 months, and 
      12 months after operation were compared, respectively. RESULTS: In group A, the 
      complete remission rates of T2DM were 20%, 36%, and 44% at 3, 6, and 12 months 
      after operation, respectively. In group B, the complete remission rates of T2DM 
      were 30.8%, 61.5%, and 88.5% at 3, 6, and 12 months after operation, 
      respectively. Besides, none of the patients with a duration more than 15 years 
      achieved complete remission. For T2DM patients with BMI < 30 kg/m(2) at 12 months 
      after LSG, the complete remission rate of T2DM was 15.4% in patients with ABCD 
      scores </= 2, and the complete remission rate of T2DM was 100% in patients with 
      ABCD scores >/= 5. CONCLUSION: LSG is safe and effective for T2DM patients with BMI 
      less than 35 kg/m(2) in the short-term. However, the complete remission rate of 
      T2DM in patients with BMI less than 30 kg/m(2) is far from the diabetes patients 
      with BMI at 30-34.9 kg/m(2).
FAU - Wu, Diqing
AU  - Wu D
AD  - Department of Bariatric and Metabolic Surgery, China-Japan Union Hospital, Jilin 
      University, No. 126 Xiantai Avenue, Changchun City, 130033, Jilin Province, 
      China.
FAU - Wang, Lun
AU  - Wang L
AD  - Department of Bariatric and Metabolic Surgery, China-Japan Union Hospital, Jilin 
      University, No. 126 Xiantai Avenue, Changchun City, 130033, Jilin Province, 
      China.
FAU - Jiang, Tao
AU  - Jiang T
AUID- ORCID: 0000-0003-2465-6007
AD  - Department of Bariatric and Metabolic Surgery, China-Japan Union Hospital, Jilin 
      University, No. 126 Xiantai Avenue, Changchun City, 130033, Jilin Province, 
      China. jiangtao1099899@163.com.
LA  - eng
PT  - Journal Article
DEP - 20200622
PL  - Germany
TA  - Surg Endosc
JT  - Surgical endoscopy
JID - 8806653
SB  - IM
MH  - *Body Mass Index
MH  - Diabetes Mellitus, Type 2/*surgery
MH  - Female
MH  - Gastrectomy/*methods
MH  - Humans
MH  - Laparoscopy/*methods
MH  - Male
MH  - Obesity, Morbid/*surgery
MH  - Treatment Outcome
MH  - Weight Loss/*physiology
OTO - NOTNLM
OT  - Body mass index
OT  - Sleeve gastrectomy
OT  - Type 2 diabetes mellitus
OT  - Weight loss
EDAT- 2020/06/24 06:00
MHDA- 2021/07/21 06:00
CRDT- 2020/06/24 06:00
PHST- 2020/03/26 00:00 [received]
PHST- 2020/06/16 00:00 [accepted]
PHST- 2020/06/24 06:00 [pubmed]
PHST- 2021/07/21 06:00 [medline]
PHST- 2020/06/24 06:00 [entrez]
AID - 10.1007/s00464-020-07749-4 [pii]
AID - 10.1007/s00464-020-07749-4 [doi]
PST - ppublish
SO  - Surg Endosc. 2021 Apr;35(4):1544-1550. doi: 10.1007/s00464-020-07749-4. Epub 2020 
      Jun 22.